Can CAR-T first movers keep pace in a rapidly evolving market?

The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market. Ben Hargreaves finds that the early leaders, Gilead and Novartis, are now facing significant challenges, as manufacturing hurdles and intensified competition threaten their ability to sustain growth and market dominance.